Combination of Nivolumab Immunotherapy with Radiation Therapy and Androgen Deprivation Therapy in the Management of Gleason Group 5 Prostate Cancer: Final Analysis of a Phase 2 Trial.
Saved in:
| Title: | Combination of Nivolumab Immunotherapy with Radiation Therapy and Androgen Deprivation Therapy in the Management of Gleason Group 5 Prostate Cancer: Final Analysis of a Phase 2 Trial. |
|---|---|
| Authors: | Bryant, J.M.1 (AUTHOR), Sandoval, M.L.1 (AUTHOR), Putney, R.1 (AUTHOR), Caslini, C.1 (AUTHOR), Katende, E.1 (AUTHOR), Fink, A.1 (AUTHOR), Trivedi, P.1 (AUTHOR), Naqvi, S.M.1 (AUTHOR), Kim, Y.2 (AUTHOR), Zhang, J.1 (AUTHOR), Park, J.1 (AUTHOR), Serna, A.1 (AUTHOR), Lam, N.B.1 (AUTHOR), Pow-Sang, J.1 (AUTHOR), Poch, M.1 (AUTHOR), Li, R.1 (AUTHOR), Manley, B.1 (AUTHOR), Naghavi, A.O.3 (AUTHOR), Torres-Roca, J.F.3 (AUTHOR), Grass, D.1 (AUTHOR) |
| Source: | International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pS57-S57. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 03603016 |
|---|---|
| DOI: | 10.1016/j.ijrobp.2024.07.094 |
